Literature DB >> 19432692

Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice.

Magnus Lindberg1, Karl-Göran Prütz, Per Lindberg, Björn Wikström.   

Abstract

Excessive interdialytic weight gain (IWG) and ultrafiltration rates (UFR) above 10 mL/h/kg body weight imply higher morbidity and mortality. This study aimed to estimate the prevalence of high fluid consumers, describe UFR patterns, and describe patient characteristics associated with IWG and UFR. The Swedish Dialysis DataBase and The Swedish Renal Registry of Active Treatment of Uremia were used as data sources. Data were analyzed from patients aged >/=18 on regular treatment with hemodialysis (HD) and registered during 2002 to 2006. Interdialytic weight gain and dialytic UFR were examined in annual cohorts and the records were based on 9693 HD sessions in 4498 patients. Differences in proportions were analyzed with the chi-square test and differences in means were tested using the ANOVA or the t test. About 30% of the patients had IWG that exceed 3.5% of dry body weight and 5% had IWG >/=5.7%. The volume removed during HD was >10 mL/h/kg for 15% to 23% of the patients, and this rate increased during the first dialytic year. Patient characteristics associated with fluid overload were younger age, lower body mass index, longer dialytic vintage, and high blood pressure. By studying IWG and dialytic UFR as quality indicators, it is shown that there is a potential for continuing improvement in the care of patients in HD settings, i.e., to enhanced adherence to fluid restriction or alternatively to extend the frequency of dialysis for all patients, e.g., by providing daily treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19432692     DOI: 10.1111/j.1542-4758.2009.00354.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  7 in total

1.  Hospital treatment for fluid overload in the Medicare hemodialysis population.

Authors:  Thomas J Arneson; Jiannong Liu; Yang Qiu; David T Gilbertson; Robert N Foley; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

2.  Individualized reduction in dialysate sodium in conventional in-center hemodialysis.

Authors:  Rohini Arramreddy; Sumi J Sun; Jair Munoz Mendoza; Glenn M Chertow; Brigitte Schiller
Journal:  Hemodial Int       Date:  2012-05-04       Impact factor: 1.812

3.  Patient's response to a simple question on recovery after hemodialysis session strongly associated with scores of comprehensive tools for quality of life and depression symptoms.

Authors:  Gildete Barreto Lopes; Luciana Ferreira Silva; Gustavo Behrens Pinto; Luiz Fernando Catto; Marcia Tereza Silva Martins; Margarida Maria Dantas Dutra; Antonio Alberto Lopes
Journal:  Qual Life Res       Date:  2014-03-14       Impact factor: 4.147

4.  Rationale and design of technology assisted stepped collaborative care intervention to improve patient-centered outcomes in hemodialysis patients (TĀCcare trial).

Authors:  Maria-Eleni Roumelioti; Jennifer L Steel; Jonathan Yabes; Kevin E Vowles; Yoram Vodovotz; Scott Beach; Bruce Rollman; Steven D Weisbord; Mark L Unruh; Manisha Jhamb
Journal:  Contemp Clin Trials       Date:  2018-09-09       Impact factor: 2.226

Review 5.  An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease.

Authors:  Kelly Lambert; Judy Mullan; Kylie Mansfield
Journal:  BMC Nephrol       Date:  2017-10-23       Impact factor: 2.388

Review 6.  Phosphate-control adherence in hemodialysis patients: current perspectives.

Authors:  Ebele M Umeukeje; Amanda S Mixon; Kerri L Cavanaugh
Journal:  Patient Prefer Adherence       Date:  2018-07-04       Impact factor: 2.711

7.  Non-adherence to hemodialysis regimens among patients on maintenance hemodialysis in sub-Saharan Africa: an example from Cameroon.

Authors:  Marie Patrice Halle; Musaga Nelson; Folefack Francois Kaze; Nda Mefo'o Jean Pierre; Tewafeu Denis; Hermine Fouda; Enow Gloria Ashuntantang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.